ProShare Advisors LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,539
+35.8%
14,512
+0.4%
0.00%
Q2 2023$25,438
-52.0%
14,454
+21.9%
0.00%
Q1 2022$53,000
-48.5%
11,861
-21.4%
0.00%
Q4 2021$103,000
-16.9%
15,084
-11.3%
0.00%
Q3 2021$124,000
-33.7%
17,002
-8.7%
0.00%
-100.0%
Q2 2021$187,000
+12.7%
18,630
+6.9%
0.00%0.0%
Q1 2021$166,000
+21.2%
17,434
+39.3%
0.00%0.0%
Q4 2020$137,00012,5160.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$7,605,0001.52%
Privium Fund Management (UK) Ltd 48,470$353,0000.38%
Pentwater Capital Management LP 4,967,227$36,211,0000.37%
J. Goldman & Co LP 301,391$2,197,0000.11%
Perceptive Advisors 787,745$5,743,0000.08%
KNOTT DAVID M 29,566$216,0000.08%
Virtus ETF Advisers LLC 23,082$168,0000.07%
Altium Capital Management LP 32,238$235,0000.06%
Advisory Services Network, LLC 268,290$1,956,0000.06%
MCF Advisors LLC 66,185$482,0000.05%
View complete list of POSEIDA THERAPEUTICS INC shareholders